Geneva Capital Management LLC Balchem Corp Transaction History

Geneva Capital Management LLC

$5.68 Billion
Q4 2024

A detailed history of Geneva Capital Management LLC transactions in Balchem Corp stock. As of the latest transaction made, Geneva Capital Management LLC holds 819,746 shares of BCPC stock, worth $140 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares

819,746

Previous 779,869 5.11%

Holding current value

$140 Million

Previous $137 Million 2.6%

% of portfolio

2.35%

Previous 2.33%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$163.0 - $183.41 $6.5 Million - $7.31 Million	39,877 Added 5.11%	819,746 $134 Million
Q3 2024 Nov 05, 2024	BUY	$154.1 - $181.56 $1.96 Million - $2.31 Million	12,750 Added 1.66%	779,869 $137 Million
Q2 2024 Aug 14, 2024	BUY	$138.5 - $156.63 $505,248 - $571,386	3,648 Added 0.48%	767,119 $118 Million
Q1 2024 May 03, 2024	SELL	$137.06 - $157.27 $512,604 - $588,189	-3,740 Reduced 0.49%	763,471 $118 Million
Q4 2023 Feb 06, 2024	BUY	$115.08 - $150.35 $447,085 - $584,109	3,885 Added 0.51%	767,211 $114 Million
Q3 2023 Nov 13, 2023	BUY	$123.38 - $142.72 $293,397 - $339,388	2,378 Added 0.31%	763,326 $94.7 Million
Q2 2023 Aug 01, 2023	SELL	$122.28 - $136.64 $406,214 - $453,918	-3,322 Reduced 0.43%	760,948 $103 Million
Q1 2023 May 12, 2023	BUY	$117.39 - $142.06 $1.64 Million - $1.98 Million	13,946 Added 1.86%	764,270 $96.7 Million
Q4 2022 Feb 07, 2023	BUY	$120.16 - $142.73 $2.86 Million - $3.39 Million	23,776 Added 3.27%	750,324 $91.6 Million
Q3 2022 Nov 02, 2022	BUY	$119.7 - $141.48 $3.62 Million - $4.28 Million	30,263 Added 4.35%	726,548 $88.3 Million
Q2 2022 Aug 02, 2022	BUY	$113.6 - $139.82 $5.46 Million - $6.72 Million	48,041 Added 7.41%	696,285 $90.3 Million
Q1 2022 May 02, 2022	SELL	$131.21 - $167.55 $404,389 - $516,389	-3,082 Reduced 0.47%	648,244 $88.6 Million
Q4 2021 Feb 02, 2022	SELL	$149.18 - $172.5 $2.11 Million - $2.45 Million	-14,176 Reduced 2.13%	651,326 $110 Million
Q3 2021 Nov 08, 2021	SELL	$129.2 - $150.61 $493,931 - $575,782	-3,823 Reduced 0.57%	665,502 $96.5 Million
Q2 2021 Aug 11, 2021	SELL	$119.87 - $133.92 $1.22 Million - $1.36 Million	-10,182 Reduced 1.5%	669,325 $87.9 Million
Q1 2021 May 03, 2021	SELL	$107.03 - $131.53 $1.52 Million - $1.86 Million	-14,170 Reduced 2.04%	679,507 $85.2 Million
Q4 2020 Feb 02, 2021	BUY	$98.58 - $115.22 $1.97 Million - $2.3 Million	19,944 Added 2.96%	693,677 $79.9 Million
Q3 2020 Nov 12, 2020	BUY	$91.61 - $103.46 $1.59 Million - $1.79 Million	17,346 Added 2.64%	673,733 $65.8 Million
Q2 2020 Aug 13, 2020	BUY	$80.3 - $102.54 $9.02 Million - $11.5 Million	112,312 Added 20.64%	656,387 $62.3 Million
Q1 2020 May 15, 2020	BUY	$81.49 - $113.6 $44.3 Million - $61.8 Million	544,075 New	544,075 $53.7 Million

Others Institutions Holding BCPC

# of Institutions

384

Shares Held

28.4M

Call Options Held

162K

Put Options Held

4.7K

View Full List

About BALCHEM CORP

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.48B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

More about BCPC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.

Account

Geneva Capital Management LLC Balchem Corp Transaction History